![logo](/logos/CNSP.webp)
CNS Pharmaceuticals, Inc.
NASDAQ:CNSP
0.14 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | CNS Pharmaceuticals, Inc. |
Symbool | CNSP |
Munteenheid | USD |
Prijs | 0.143 |
Beurswaarde | 4,603,364 |
Dividendpercentage | 0% |
52-weken bereik | 0.096 - 137.5 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. John Michael Climaco Esq., J.D. |
Website | https://www.cnspharma.com |
An error occurred while fetching data.
Over CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)